488 related articles for article (PubMed ID: 16144854)
1. Folic acid deficiency modifies the haematopoietic response to recombinant human erythropoietin in maintenance dialysis patients.
Schiffl H; Lang SM
Nephrol Dial Transplant; 2006 Jan; 21(1):133-7. PubMed ID: 16144854
[TBL] [Abstract][Full Text] [Related]
2. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
Mircescu G; Gârneata L; Capusa C; Ursea N
Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
[TBL] [Abstract][Full Text] [Related]
3. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
4. High-dose folic acid supplements and responsiveness to rHu-EPO in HD patients.
Sepe V; Adamo G; Giuliano MG; Soccio G; Libetta C; Dal Canton A
Nephrol Dial Transplant; 2006 Jul; 21(7):2036. PubMed ID: 16504977
[No Abstract] [Full Text] [Related]
5. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3.
Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P
Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544
[TBL] [Abstract][Full Text] [Related]
6. Validation of a composite scoring scheme in the diagnosis of folate deficiency in a pediatric and adolescent dialysis cohort.
Kaskel FJ; Bamgbola OF
J Ren Nutr; 2008 Sep; 18(5):430-9. PubMed ID: 18721738
[TBL] [Abstract][Full Text] [Related]
7. [Is it necessary to supplement with folic acid patients in chronic dialysis treated with erythropoietin?].
Duclos J; Sieberth HG; Mann H
Rev Med Chil; 1993 Jan; 121(1):30-5. PubMed ID: 8235161
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.
Nampoory MR; Johny KV; al-Hilali N; Seshadri MS; Kanagasabhapathy AS
Nephrol Dial Transplant; 1996 Jan; 11(1):177-81. PubMed ID: 8649630
[TBL] [Abstract][Full Text] [Related]
9. Anaemia, iron studies and erythropoietin in patients of chronic renal failure.
Singh NP; Aggarwal L; Singh T; Anuradha S; Kohli R
J Assoc Physicians India; 1999 Mar; 47(3):284-90. PubMed ID: 10999121
[TBL] [Abstract][Full Text] [Related]
10. [Anemia management in haemodialysis. EuCliD database in Spain].
Avilés B; Coronel F; Pérez-García R; Marcelli D; Orlandini G; Ayala JA; Rentero R
Nefrologia; 2002; 22(6):555-63. PubMed ID: 12516289
[TBL] [Abstract][Full Text] [Related]
11. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
Sinnassamy P; Andre JL; Treize G; Leroy B
Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
[TBL] [Abstract][Full Text] [Related]
12. Use of red blood cell indices (MCV, MCH, RDW) in monitoring chronic hemodialysis patients treated with recombinant erythropoietin.
Fialon P; Leaute AG; Sassier P; Vallot C; Wone C
Pathol Biol (Paris); 1993 Dec; 41(10):931-5. PubMed ID: 8159473
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin, folic acid deficiency and hyperhomocysteinemia: is there a possible relationship in chronically hemodialyzed patients?
Korzets A; Ori Y; Chagnac A; Weinstein T; Herman M; Zevin D; Malachi T; Gafter U
Clin Nephrol; 2000 Jan; 53(1):48-54. PubMed ID: 10661482
[TBL] [Abstract][Full Text] [Related]
14. [Macrocytic anaemia with folic acid deficiency in hypothyroidism (author's transl)].
Streuli R; Rhyner K
Dtsch Med Wochenschr; 1978 Jun; 103(22):936-9. PubMed ID: 657977
[TBL] [Abstract][Full Text] [Related]
15. Intravenous administration of vitamin B12 in the treatment of hyperhomocysteinemia associated with end-stage renal disease.
Vrentzos GE; Papadakis JA; Vardakis KE; Maliaraki N; Stilianou K; Arvanitis A; Sratigis S; Alivanis P; Margioris AN; Ganotakis ES
J Nephrol; 2003; 16(4):535-9. PubMed ID: 14696755
[TBL] [Abstract][Full Text] [Related]
16. Efficacy prospective study of different frequencies of Epo administration by i.v. and s.c. routes in renal replacement therapy patients.
Messa P; Nicolini MA; Cesana B; Brezzi B; Zattera T; Magnasco A; Moroni G; Campise M
Nephrol Dial Transplant; 2006 Feb; 21(2):431-6. PubMed ID: 16249199
[TBL] [Abstract][Full Text] [Related]
17. Correlates of habitual physical activity in chronic haemodialysis patients.
Zamojska S; Szklarek M; Niewodniczy M; Nowicki M
Nephrol Dial Transplant; 2006 May; 21(5):1323-7. PubMed ID: 16421165
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
[TBL] [Abstract][Full Text] [Related]
19. Megaloblastic marrow in macrocytic anaemias at Kenyatta National and M P Shah Hospitals, Nairobi.
Mwanda OW; Dave P
East Afr Med J; 1999 Nov; 76(11):610-4. PubMed ID: 10734519
[TBL] [Abstract][Full Text] [Related]
20. Macrocytic anaemia.
Jackson JM; Davis RE
Aust Fam Physician; 1979 Apr; 8(4):369, 371-3, 375-8 passim. PubMed ID: 454310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
